At Lycia, we aim to eliminate the source of disease using the power of extracellular protein degradation. Our novel LYTAC therapeutics are designed to bind and remove disease-causing extracellular proteins by directing them into the cell for degradation via the lysosome. Focused initially on autoimmune and inflammatory diseases, our platform addresses gaps in targeting proteins outside the cell, offering new hope to patients who urgently need better options.
Company Details
- Employees
- 40
- Founded
- -
- Address
- E Jamie Ct, South San Francisco,california 94080,united States
- Phone
- (650) 686-8821
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- lyciatx.com
- HQ
- South San Francisco, California
Lycia Therapeutics Questions
Lycia Therapeutics's helpline number is (650) 686-8821
Lycia Therapeutics's website is lyciatx.com
Lycia Therapeutics's LinkedIn profile is https://www.linkedin.com/company/lycia-therapeutics
Lycia Therapeutics has
40 employees.
View email and phone details for 40
employees at Lycia Therapeutics.
Lycia Therapeutics's industry is
Biotechnology Research
Lycia Therapeutics's top competitors are
Maze Therapeutics,
Denali Therapeutics,
Xaira Therapeutics,
Kimia Therapeutics,
Ajax Therapeutics,
Carmot Therapeutics, Inc.,
Uniquity Bio,
Nurix Therapeutics,
Vicinitas Therapeutics,
Arsenal Biosciences, Inc..
Lycia Therapeutics's categories are Biotechnology Research
Lycia Therapeutics's founding year is 2020
